Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement

IMPORTANCE: Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS inhibitor may reverse left ventricular remodeling and improve function. OBJECTIVE: To investigate the association of prescript...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA
Main Authors: Inohara, Taku, Manandhar, Pratik, Kosinski, Andrzej S., Matsouaka, Roland A., Kohsaka, Shun, Mentz, Robert J., Thourani, Vinod H., Carroll, John D., Kirtane, Ajay J., Bavaria, Joseph E., Cohen, David J., Kiefer, Todd L., Gaca, Jeffrey G., Kapadia, Samir R., Peterson, Eric D., Vemulapalli, Sreekanth
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2018
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583475/
https://ncbi.nlm.nih.gov/pubmed/30512100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.18077
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares